Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation, Panel E, Funding Opportunity Announcement (FOA) PAR07-231, 14132-14133 [E9-7015]
Download as PDF
<![CDATA[
14132
Federal Register / Vol. 74, No. 59 / Monday, March 30, 2009 / Notices
Research Dissertation, Panel H, FOA PAR07–
231.’’
For More Information Contact: Maurine F.
Goodman, M.A., M.P.H., Scientific Review
Officer, Office of the Director, Office of the
Chief Science Officer, CDC, 1600 Clifton
Road, NE., Mailstop D72, Atlanta, GA 30333,
Telephone: (404) 639–4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–6989 Filed 3–27–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Strengthening
Infectious Disease Research Capacity
for Public Health Action in Guatemala
and Central America, Funding
Opportunity Announcement (FOA)
GH09–001
sroberts on PROD1PC70 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 2 p.m.–5 p.m., April 30,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Strengthening Infectious
Disease Research Capacity for Public Health
Action in Guatemala and Central America,
FOA GH09–001.’’
For Further Information Contact: Maurine
F. Goodman, M.A., M.P.H., Scientific Review
Officer, Office of the Director, Office of the
Chief Science Officer, CDC, 1600 Clifton
Road, NE., Mailstop D74, Atlanta, GA 30333,
Telephone: (404) 639–4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Nov<24>2008
18:33 Mar 27, 2009
Jkt 217001
Dated: March 20, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
[FR Doc. E9–6990 Filed 3–27–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control
Special Emphasis Panel (SEP): CDC
Grants for Public Health Research
Dissertation, Panel D, Funding
Opportunity Announcement (FOA)
PAR07–231
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 9 p.m.–5 a.m., May 14,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘CDC Grants for Public Health
Research Dissertation, Panel D, FOA PAR07–
231.’’
Contact Person for More Information:
Susan B. Stanton, D.D.S., Scientific Review
Officer, Office of the Director, Office of the
Chief Science Officer, CDC, 1600 Clifton
Road, NE., Mailstop D72, Atlanta, GA 30333,
Telephone: (404) 639–4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–7010 Filed 3–27–09; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Addressing
Emerging Infectious Diseases in
Bangladesh, Funding Opportunity
Announcement (FOA) Number CI 09–
002
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.–2 p.m., May 6,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of an application received in
response to ‘‘Addressing Emerging Infectious
Diseases in Bangladesh, FOA CI 09–002.’’
Contact Person for More Information:
Gregory Anderson, M.P.H., M.S., Scientific
Review Administrator, Strategic Science and
Program Unit, Office of the Director,
Coordinating Center for Infectious Diseases,
CDC, 1600 Clifton Road, Mailstop E–60,
Atlanta, GA 30333, Telephone: (404) 498–
2275.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–7012 Filed 3–27–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation,
Panel E, Funding Opportunity
Announcement (FOA) PAR07–231
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
Frm 00028
Fmt 4703
Sfmt 4703
E:\FR\FM\30MRN1.SGM
30MRN1
Federal Register / Vol. 74, No. 59 / Monday, March 30, 2009 / Notices
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 2 p.m.—4 p.m., May 5,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘CDC Grants for Public Health
Research Dissertation, Panel E, FOA PAR07–
231.’’
For Further Information Contact: Susan B.
Stanton, D.D.S., Scientific Review Officer,
Office of the Director, Office of the Chief
Science Officer, CDC, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone:
(404) 639–4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
For Further Information Contact: Christine
J. Morrison, PhD, Scientific Review Officer,
Office of the Director, Office of the Chief
Science Officer, CDC, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone:
(404) 639–3098.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–7059 Filed 3–27–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–7015 Filed 3–27–09; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation,
Panel J, Funding Opportunity
Announcement (FOA) PAR07–231
BILLING CODE 4163–18–P
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation,
Panel G, Funding Opportunity
Announcement (FOA) PAR07–231
sroberts on PROD1PC70 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.—3 p.m., May 12,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘CDC Grants for Public Health
Research Dissertation, Panel G, FOA PAR07–
231.’’
VerDate Nov<24>2008
18:33 Mar 27, 2009
Jkt 217001
Time and Date: 1:30 p.m.–3 p.m., May 14,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘CDC Grants for Public Health
Research Dissertation, Panel J, FOA PAR07–
231.’’
Contact Person for More Information:
Maurine F. Goodman, M.A., M.P.H.,
Scientific Review Officer, Office of the
Director, Office of the Chief Science Officer,
CDC, 1600 Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone: (404) 639–
4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
14133
Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–7062 Filed 3–27–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9:30 a.m.–5 p.m., April 16,
2009.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone: (859) 334–4611, Fax: (859) 334–
4619.
Status: Open to the public, but without a
public oral comment period. To access by
conference call dial the following
information 1–(866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
E:\FR\FM\30MRN1.SGM
30MRN1
]]>Agencies
[Federal Register Volume 74, Number 59 (Monday, March 30, 2009)]
[Notices]
[Pages 14132-14133]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-7015]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for Public Health Research
Dissertation, Panel E, Funding Opportunity Announcement (FOA) PAR07-231
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act
[[Page 14133]]
(Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 2 p.m.--4 p.m., May 5, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
``CDC Grants for Public Health Research Dissertation, Panel E, FOA
PAR07-231.''
For Further Information Contact: Susan B. Stanton, D.D.S.,
Scientific Review Officer, Office of the Director, Office of the
Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone: (404) 639-4640.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 23, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-7015 Filed 3-27-09; 8:45 am]
BILLING CODE 4163-18-P
